BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 10553081)

  • 1. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response.
    Kedl RM; Mescher MF
    J Immunol; 1998 Jul; 161(2):674-83. PubMed ID: 9670942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.
    Debes GF; Bonhagen K; Wolff T; Kretschmer U; Krautwald S; Kamradt T; Hamann A
    J Virol; 2004 Jul; 78(14):7528-35. PubMed ID: 15220427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory precursor phenotype of CD8+ T cells reflects early antigenic experience rather than memory numbers in a model of localized acute influenza infection.
    Croom HA; Denton AE; Valkenburg SA; Swan NG; Olson MR; Turner SJ; Doherty PC; Kedzierska K
    Eur J Immunol; 2011 Mar; 41(3):682-93. PubMed ID: 21264852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines.
    Cerwenka A; Carter LL; Reome JB; Swain SL; Dutton RW
    J Immunol; 1998 Jul; 161(1):97-105. PubMed ID: 9647212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
    Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cells responding to influenza infection reach and persist at higher numbers than CD4+ T cells independently of precursor frequency.
    Powell TJ; Brown DM; Hollenbaugh JA; Charbonneau T; Kemp RA; Swain SL; Dutton RW
    Clin Immunol; 2004 Oct; 113(1):89-100. PubMed ID: 15380534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitatively different memory CD8+ T cells are generated after lymphocytic choriomeningitis virus and influenza virus infections.
    Mueller SN; Langley WA; Li G; García-Sastre A; Webby RJ; Ahmed R
    J Immunol; 2010 Aug; 185(4):2182-90. PubMed ID: 20639484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig.
    Topham DJ; Tripp RA; Hamilton-Easton AM; Sarawar SR; Doherty PC
    J Immunol; 1996 Oct; 157(7):2947-52. PubMed ID: 8816401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
    Zimmermann C; Pircher H
    J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
    Lukacher AE; Moser JM; Hadley A; Altman JD
    J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection.
    Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
    Eur J Immunol; 2001 May; 31(5):1523-30. PubMed ID: 11465109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.
    Oehen S; Brduscha-Riem K
    J Immunol; 1998 Nov; 161(10):5338-46. PubMed ID: 9820507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells.
    Ishikawa H; Tanaka K; Kutsukake E; Fukui T; Sasaki H; Hata A; Noda S; Matsumoto T
    Virology; 2010 Nov; 407(2):325-32. PubMed ID: 20855097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Lightman S; Cobbold S; Waldmann H; Askonas BA
    Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
    Kosaka A; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
    Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 1999 Jun; 162(11):6671-80. PubMed ID: 10352285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.